Ozempic

Healthcare

Hims Teams up with Novo to Compete for Weight Loss Scripts

Photo via Michael Siluk/UCG/Universal Images Group/Newscom

The two struck a deal Monday for Hims to offer official versions of Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy.

2 min read

Photo via Ritzau Scanpix/Sipa USA/Newscom

Healthcare

Novo Nordisk Launches Suit to Knock Out Hims & Hers’ Weight Loss Knockoffs

Novo’s Copenhagen-listed shares rose 5.2% on Monday. New York-listed shares in Hims & Hers, meanwhile, shed an Ozempic-like 16% in volume.

2 min read
Photo by JHVEPhoto via iStock

Healthcare

Treatment Advances Position Lilly as Weight-Loss Heavyweight

The proliferation of cheaper generic drugs and more competition has already begun to bring down prices on weight-loss treatments.

2 min read
Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Healthcare

Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments

The company also said earlier this week it will drop $6 billion on a new manufacturing facility in Huntsville, Alabama.

2 min read

Healthcare

Eli Lilly’s Sterling Results Highlight Rival Novo Nordisk’s Fading Fortunes

Photo by Douglas Cliff via iStock

Record performance of its GLP-1 drugs sent shares in Eli Lilly soaring almost 4% after its earnings call on Thursday.

2 min read

Healthcare

Eli Lilly Skyrockets After Promising Results for First Weight-Loss Pill

Photo by JHVEPhoto via iStock

The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.

2 min read

Healthcare

Merck Cautiously Enters GLP-1 Fray Via Licensing Deal With Chinese Drugmaker

Photo by Coolcaesar via CC BY-SA 4.0

By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.